Showing results (181-190 of 207) with videos related to

Sort By:
Pageof 21
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivoS M Grunewald, A Werthmann, B Schnarr, et al.
Die Rehabilitation|November 13, 2013
[Education, advanced and further training in the field "psychology in rehabilitation"]J Bengel, H Gall, G Grande, et al.
Surgical Endoscopy|March 21, 2025
Robotic versus laparoscopic cholecystectomy for difficult gallbladders: an observational study of tertiary centre casesMichal Kawka, Zaynab A R Jawad, David Hakim, et al.
Oncotarget|February 19, 2019
Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?Tamara M H Gall, Gareth Gerrard, Adam E Frampton, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2016
[Risk stratification and follow-up assessment of patients with pulmonary arterial hypertension: Recommendations of the Cologne Consensus Conference 2016]H H Leuchte, H Ten Freyhaus, H Gall, et al.
The European Respiratory Journal|March 3, 2009
Long-term outcome with intravenous iloprost in pulmonary arterial hypertensionM M Hoeper, H Gall, H J Seyfarth, et al.
Cancer Research|February 1, 1993
Delayed-type hypersensitivity reactions to tumor-associated antigens in colon carcinoma patients immunized with an autologous tumor cell/Bacillus Calmette-Guérin vaccineE Bloemena, H Gall, J H Ransom, et al.
The Journal of Investigative Dermatology|January 1, 1992
Migration of a human keratinocyte cell line (HACAT) to interstitial collagen type I is mediated by the alpha 2 beta 1-integrin receptorK Scharffetter-Kochanek, C E Klein, G Heinen, et al.
Herzschrittmachertherapie & Elektrophysiologie|June 3, 2015
Ventricular tachycardias in patients with pulmonary hypertension: an underestimated prevalence? A prospective clinical studyDirk Bandorski, D Erkapic, J Stempfl, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase I study of Brequinar sodium (NSC 368390) in patients with solid malignanciesG Schwartsmann, P Dodion, J B Vermorken, et al.
Pageof 21